MaxCyte, Inc. (MXCT) stock
MXCTNasdaqServices-Commercial Physical & Biological ResearchFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 10, 2026Score 9/3065% below fair value
$1.17−0.01 (-0.85%)
Close on Nov 17, 2026Market cap $120.75MP/E –Yield –
MaxCyte operating cash flow
Operating cash flow is the cash the business generates from its day-to-day operations.
MaxCyte's operating cash flow for the twelve months ending Jun 30, 2026 was -$22.98M. For fiscal 2025 it was -$34.41M. The highest annual figure on record is -$8.78M in fiscal 2020.
Annual operating cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$34.41M | – |
| FY2024 | Dec 31, 2024 | -$27.61M | – |
| FY2023 | Dec 31, 2023 | -$21.69M | – |
| FY2022 | Dec 31, 2022 | -$14.78M | – |
| FY2021 | Dec 31, 2021 | -$10.68M | – |
| FY2020 | Dec 31, 2020 | -$8.78M | – |
| FY2019 | Dec 31, 2019 | -$8.80M | – |
Quarterly operating cash flow
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -$4.66M | – |
| Q1 FY2026 | Mar 31, 2026 | -$8.17M | – |
| Q4 FY2025 | Dec 31, 2025 | -$2.69M | – |
| Q3 FY2025 | Sep 30, 2025 | -$7.46M | – |
| Q2 FY2025 | Jun 30, 2025 | -$9.85M | – |
| Q1 FY2025 | Mar 31, 2025 | -$14.41M | – |
| Q4 FY2024 | Dec 31, 2024 | -$7.82M | -897.2% |
| Q3 FY2024 | Sep 30, 2024 | -$4.39M | – |
| Q2 FY2024 | Jun 30, 2024 | -$4.83M | – |
| Q1 FY2024 | Mar 31, 2024 | -$10.56M | – |
| Q4 FY2023 | Dec 31, 2023 | $981.00K | – |
| Q3 FY2023 | Sep 30, 2023 | -$8.24M | – |
| Q2 FY2023 | Jun 30, 2023 | -$10.11M | -1200.0% |
| Q1 FY2023 | Mar 31, 2023 | -$4.32M | – |
| Q4 FY2022 | Dec 31, 2022 | -$6.09M | – |
| Q3 FY2022 | Sep 30, 2022 | -$5.92M | – |
| Q2 FY2022 | Jun 30, 2022 | $918.60K | – |
| Q1 FY2022 | Mar 31, 2022 | -$3.69M | – |
| Q4 FY2021 | Dec 31, 2021 | -$960.25K | – |
| Q3 FY2021 | Sep 30, 2021 | -$690.45K | – |
| Q2 FY2021 | Jun 30, 2021 | -$4.39M | – |
| Q1 FY2021 | Mar 31, 2021 | -$4.64M | – |
| Q4 FY2020 | Dec 31, 2020 | -$1.91M | – |
| Q3 FY2020 | Sep 30, 2020 | -$830.30K | – |
See a number that looks wrong?